🗓️ November 4, 2026  |  11:00 AM – 12:00 PM ET 🌐 Live Online Webinar ⏱️ 60 Minutes
Illustration for GCP E6(R3): What Inspectors Will Test in Sponsor Oversight
Clinical Research & GCP

GCP E6(R3):
What Inspectors Will Test in Sponsor Oversight

Establish a clearer oversight strategy, align supplier arrangements with ICH-GCP E6(R3), and prepare documentation and contractual evidence that supports inspection readiness.

📅 November 4, 2026
⏰ 11:00 AM – 12:00 PM ET
⏱️ 60 Minutes
🌐 Online Event

Secure Your Spot

📅
DateNovember 4, 2026
⏰
Time11:00 AM – 12:00 PM ET
⏱️
Duration60 Minutes
🌐
FormatLive Online Webinar
Register Now →

Includes live access & recording

Turning E6(R3) Oversight Expectations Into Inspection Readiness

Sponsor oversight under ICH-GCP E6(R3) places strengthened expectations on how sponsors direct, document, and demonstrate oversight of clinical trials, including activities performed by external suppliers. Inspection readiness therefore depends on more than having oversight responsibilities assigned. Sponsors need a clear strategy, supporting documentation, and contractual arrangements that show how oversight is planned and maintained in line with GCP expectations.

This webinar examines sponsor oversight requirements alongside common FDA and EMA inspection findings, connecting regulatory expectations with practical inspection preparation. Participants will consider what sponsor oversight means under E6(R3), what inspection readiness requires, and how oversight plans and records should support the sponsor's approach.

Particular attention is given to external suppliers, where responsibilities, contractual requirements, and the oversight strategy need to provide inspectors with clear evidence of how sponsor responsibilities are being addressed.

Understand What Inspectors Expect From Sponsor Oversight

Develop a clearer understanding of what sponsor oversight means under ICH-GCP E6(R3) and how inspectors may assess it. Reviewing FDA and EMA inspection findings helps clinical and quality teams connect the revised expectations with the oversight evidence they need to maintain when preparing for regulatory inspection.


Strengthen Oversight of External Suppliers. Strengthen the ability to establish an oversight strategy when clinical trial activities involve external suppliers. By connecting oversight plans, supporting documentation, and contractual requirements, sponsors can prepare clearer evidence of how responsibilities are managed and demonstrate that their oversight approach is aligned with inspector expectations.

What You Will Learn

By the end of this session, participants will be equipped to plan, document, and demonstrate sponsor oversight that stands up to inspection.

1

Interpret ICH-GCP E6(R3) sponsor oversight requirements.

2

Learn from FDA and EMA inspection findings related to sponsor oversight.

3

Prepare sponsor oversight documentation for inspection readiness.

4

Build oversight plans for clinical trial activities.

5

Use contractual requirements to support sponsor oversight.

6

Define an oversight strategy when working with external suppliers.

Key Takeaways from This Training

Focused areas that will strengthen how your organization demonstrates sponsor oversight to inspectors.

📘

E6(R3) Expectations

Understand the strengthened sponsor oversight expectations in ICH-GCP E6(R3).

🔍

Inspection Findings

Connect common FDA and EMA findings to the oversight evidence inspectors look for.

📝

Plans & Records

Make oversight plans and documentation reflect how oversight is actually planned and maintained.

🤝

Supplier Oversight

Align contracts and oversight strategy for activities performed by external suppliers.

Full Session Curriculum

Translating strengthened oversight expectations into practical inspection preparation.

✓ ICH-GCP E6(R3) sponsor oversight requirements
✓ FDA and EMA inspection findings related to sponsor oversight
✓ Sponsor oversight documentation for inspection readiness
✓ Oversight plans for clinical trial activities
✓ Contractual requirements supporting sponsor oversight
✓ Oversight strategy when working with external suppliers

This Webinar Is Designed For

Clinical, quality, and compliance professionals responsible for sponsor oversight and GCP inspection readiness.

🩺

Clinical Operations Departments

🛡️

Quality Assurance Departments

🏛️

Regulatory Affairs Departments

📋

Clinical Project Managers

🔬

Clinical Research Associates

🧪

Clinical Trial Managers

👨‍⚕️

Principal Investigators and Study Coordinators

🏢

Sponsors and CRO Representatives

🧾

GCP Auditors

⚖️

Compliance Managers

The Regulatory Landscape Behind This Webinar

ICH-GCP E6(R3) strengthens expectations for how sponsors direct, document, and demonstrate oversight of clinical trials — including activities delegated to external suppliers such as CROs and vendors. Assigning oversight responsibilities is no longer enough on its own.

FDA and EMA inspection findings frequently point to oversight that was planned but not evidenced, contracts that did not clearly define responsibilities, or records that did not show how the sponsor actually maintained control.

This webinar connects E6(R3) requirements with those findings and shows how oversight plans, documentation, and contractual arrangements can give inspectors clear evidence of how sponsor responsibilities are being met.

Reserve Your Seat Today

Don't miss this essential training on what inspectors will test in sponsor oversight under ICH-GCP E6(R3). Secure your spot now.

📅 November 4, 2026
⏰ 11:00 AM – 12:00 PM ET
🌐 Live Online
⏱️ 60 Minutes
Register Now →
Register Now — November 4, 2026
← Explore all webinars   ·   Registration and payments are completed on educraft.us.